{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:45:09Z","timestamp":1784641509269,"version":"3.55.0"},"reference-count":31,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2023,10,3]]},"DOI":"10.1080\/14740338.2023.2223955","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T20:11:33Z","timestamp":1686341493000},"page":"985-994","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":23,"title":["Investigating the risk of deep vein thrombosis with JAK inhibitors: a disproportionality analysis using FDA Adverse Event Reporting System Database (FAERS)"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-1024","authenticated-orcid":false,"given":"Shefin","family":"Mytheen","sequence":"first","affiliation":[{"name":"Nirmala College of Pharmacy, Kerala University of Health Sciences, Thrissur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2645-2094","authenticated-orcid":false,"given":"Anju","family":"Varghese","sequence":"additional","affiliation":[{"name":"Nirmala College of Pharmacy, Kerala University of Health Sciences, Thrissur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6643-2736","authenticated-orcid":false,"given":"Jismol","family":"Joy","sequence":"additional","affiliation":[{"name":"Nirmala College of Pharmacy, Kerala University of Health Sciences, Thrissur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1596-3825","authenticated-orcid":false,"given":"Anakha","family":"Shaji","sequence":"additional","affiliation":[{"name":"Nirmala College of Pharmacy, Kerala University of Health Sciences, Thrissur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-3523","authenticated-orcid":false,"given":"Antriya Annie","family":"Tom","sequence":"additional","affiliation":[{"name":"Nirmala College of Pharmacy, Kerala University of Health Sciences, Thrissur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.2147\/IPRP.S105881"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.302"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4672"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.849758"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","unstructured":"Zeba Z Shettigar A Lukose L et al. Disproportionality Analysis of Tumour Lysis Syndrome (TLS) Associated with Bruton\u2019s Tyrosine Kinase Inhibitor (BTKi) using Food and Drug Administration Adverse Events Reporting System (FAERS) database. Jul 18th 2022. doi: 10.21203\/rs.3.rs-1849066\/v1","DOI":"10.21203\/rs.3.rs-1849066\/v1"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157753"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0018578719882323"},{"issue":"3","key":"e_1_3_4_9_1","first-page":"152","article-title":"Safety profile of levonorgestrel: a disproportionality analysis of food and drug administration adverse event reporting system (Faers) database","volume":"19","author":"Kurian A","year":"2018","unstructured":"Kurian A, Kaushik K, Subeesh V, et al. Safety profile of levonorgestrel: a disproportionality analysis of food and drug administration adverse event reporting system (Faers) database. J Reprod Infertil. 2018 Jul;19(3):152\u2013156. PMID: 30167396; PMCID: PMC6104423.","journal-title":"J Reprod Infertil"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01018-z"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08786-6"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.792877"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031246"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106362"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key225"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00958-9"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031994"},{"key":"e_1_3_4_19_1","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Helath. [Accessed [3-Jan-2023]]. Available at: https:\/\/www.covid19treatmentguidelines.nih.gov\/"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1799975"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052449"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0503-6"},{"key":"e_1_3_4_23_1","unstructured":"FDA. FDA Adverse Events Reporting System (FAERS) public dashboard. 2017. https:\/\/fis.fda.gov\/sense\/app\/777e9f4d-0cf8-448e-8068-f564c31baa25\/sheet\/7a47a261-d58b-4203-a8aa-6d30 21737452\/state\/analysis."},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0622-2"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01082-y"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-020-00775-w"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101643"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23964"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102039"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.800492"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080738"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113168"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2223955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T12:58:13Z","timestamp":1695301093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2223955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,3]]}},"alternative-id":["10.1080\/14740338.2023.2223955"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2223955","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}